Victoria Werth, MD
Enriched profileProfessor of Dermatology and Medicine, Perelman School of Medicine, University of Pennsylvania; Chief, Division of Dermatology, Philadelphia VA Medical Center · Perelman School of Medicine at the University of Pennsylvania
Victoria Werth is Professor of Dermatology and Medicine, Perelman School of Medicine, University of Pennsylvania; Chief, Division of Dermatology, Philadelphia VA Medical Center at Perelman School of Medicine at the University of Pennsylvania. OpenAlex indexes 792 publications with 31,737 citations (h-index 83); ClinicalTrials.gov lists 11 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Dermatology profiles in the findmyKOL directory.
Data verified 25 Aug 2026
Overview
Updated 27 Aug 2026
Victoria P. Werth, MD, is Professor of Dermatology and Medicine, Perelman School of Medicine, University of Pennsylvania at Perelman School of Medicine at the University of Pennsylvania. The public record shows 792 publications with 31,737 citations (h-index 83), centered on Dermatology. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 35 companies, 7 NIH-funded awards (2001–2026).
- Most recent indexed publication: 2026 · Lupus science & medicine
- Top research focus: Dermatology
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 35 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 61 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- A Study of Quinacrine in Participants With Cutaneous Lupus Erythematosus
Sponsor: Victoria Werth
- Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Sponsor: Corbus Pharmaceuticals Inc.
- Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)
Sponsor: University of Pennsylvania
Industry payments
Updated 27 Aug 2026
35 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Regeneron Pharmaceuticals, Inc.Program year202537 payments$60,330openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year202521 payments$20,521openpaymentsdata.cms.gov ↗
- Merck KGaAProgram year20255 payments$17,992openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Antiparasitic
20.2%Antimalarial20.2%Hydroxychloroquine Sulfate92%Chloroquine Phosphate8%Part D<11 patientsCancer & immunology
17.1%Folate Analog Metabolic Inhibitor12.9%Methotrexate100%Part D≥26 patientsCalcineurin inhibitor3%Tacrolimus100%Part D≥12 patientsDermatology
16.1%Corticosteroid8.4%Triamcinolone Acetonide100%Part D≥54 patientsInterleukin-4 Receptor alpha Antagonist6.6%Dupixent Pen80%Dupixent Syringe20%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
7 NIH research awards on record, funded 2001–2026 per NIH RePORTER. The latest:
- Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)
New York University School of Medicine
FY2026$1,149,761UC2AR081039 - Extracellular vesicles as a novel mediator for ultraviolet-B light induced photoaging and skin inflammation.
Philadelphia Va Medical Center
FY2026I01BX005921 - Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)
New York University School of Medicine
FY2025$1,249,871UC2AR081039
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Qualitative interview study in patients with SLE to assess patient perception of fatigue and skin-related symptoms.
Lupus science & medicine
Article2026 - Rapid Onset of Response in Adults with Dermatomyositis Receiving Dazukibart: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study.
Clinical, cosmetic and investigational dermatology
Article2026 - Recommendations for the diagnostic work-up of cutaneous small vessel vasculitis - Position Statement of the European Academy of Dermatology and Venereology Vasculitis and Vasculopathy Task Force.
Journal of the European Academy of Dermatology and Venereology
Guideline2026 - A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus.
The Journal of rheumatology
Article2026
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/victoria-werth-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Victoria-P-Werth-38760885
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/lupusresearchalliance/posts/-meet-dr-victoria-werth-a-dedicated-researcher-whos-on-a-mission-to-find-better-/888741206626361
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.upenn.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.upenn.edu ↗
- Board Certified
Dermatology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
Editorial & leadership roles
journal and society appointments- Co-founder and past president
Rheumatologic Dermatology Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗ - Co-founder
Medical Dermatology Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗ - Editorial Advisory Board
British Journal of Dermatology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →academic.oup.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dermatologyfocus.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dermatologyfocus.org ↗
- Lifetime Achievement Award
Medical Dermatology Society
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →skinofcolorsociety.org ↗
Secondary affiliations
appointments beyond the home institution- Chief
Division of Dermatology, Philadelphia Veterans Affairs Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pennmedicine.org ↗
Media & interviews
press, podcasts and appearances- Guest
Derm Club Podcast (Dr. Hannah Kopelman), discussion of lupus treatment and pathophysiology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hannahkopelman.com ↗ - Interview guest
AAD Dialogues in Dermatology podcast, dermatomyositis subtypes and clinical progression
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →resources.aad.org ↗ - Featured expert
"TMA Ask The Doc: Dermatology" webinar, The Myositis Association
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →myositis.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Francis Marchlinski, MD
Perelman School of Medicine at the University of Pennsylvania
Stephen Schuster, MD
Perelman School of Medicine at the University of Pennsylvania
Jay Giri, MD
Perelman School of Medicine at the University of Pennsylvania
Michael Thase, MD
Perelman School of Medicine at the University of Pennsylvania